Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Life Technologies, FTC; Abbott; Saladax; PerkinElmer; Vermillion; More

NEW YORK (GenomeWeb News) – Life Technologies said late last week in a regulatory filing that it has received a second request from the US Federal Trade Commission for more information about its pending $13.6 billion sale to Thermo Fisher Scientific. The company said it is cooperating with FTC and continues to expect the acquisition to close in early 2014.


Abbott's board has approved a new stock buyback program for up to $3 billion and a quarterly dividend of $.14 per share. The share buyback program replaces Abbott's previous $5 billion program announced in late 2008, which was recently completed. The $.14 dividend is payable Aug. 15 to shareholders of record at the close of business on July 15.


Saladax Biomedical has been certified as a registered CLIA laboratory from the Office of Clinical Standards and Quality, a division of CMS. The certification allows the company to start clinical laboratory operations for the MyCare portfolio of products at its Bethlehem, Pa., facilities. The company's Saladax Biomedical Laboratories division will initially offer testing services for chemotherapy exposure optimization assays, such as My5-FU, MyPaclitaxel, and MyDocetaxel in the US, it said.


PerkinElmer's board has declared a regular quarterly dividend of $0.07 per share to shareholders of record at the close of business on July 19. The dividend is payable on Aug. 9.


Emerging Growth Equities initiated coverage of Vermillion with a Buy rating and price target of $4.00 on the Austin, Texas-based firm's stock.


JEOL has concluded an original equipment manufacturing agreement with Zoex to offer Zoex's comprehensive two-dimensional gas chromatography technology with JEOL's new AccuTOF GCV 4G high-resolution time-of-flight mass spectrometry platform. Terms of the deal were not disclosed.


The College of American Pathologists has renewed CAP 15189 accreditation for National Jewish Health Advanced Diagnostic Laboratories, an esoteric clinical lab. The accreditation is based on Standard 15189 for laboratory technical competence and continual quality management. It is administered by the International Organization for Standardization, and currently only 22 US labs have earned the accreditation.


In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.